-
1
-
-
0023748414
-
Genetic alterations during colorectal-tumor development
-
Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
-
(1988)
N Engl J Med
, vol.319
, pp. 525-532
-
-
Vogelstein, B.1
Fearon, E.R.2
Hamilton, S.R.3
Kern, S.E.4
Preisinger, A.C.5
Leppert, M.6
-
2
-
-
33745541234
-
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
-
[see comment]
-
Weisenberger D.J., Siegmund K.D., Campan M., Young J., Long T.I., Faasse M.A., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. [see comment]. Nat Genet 38 (2006) 787-793
-
(2006)
Nat Genet
, vol.38
, pp. 787-793
-
-
Weisenberger, D.J.1
Siegmund, K.D.2
Campan, M.3
Young, J.4
Long, T.I.5
Faasse, M.A.6
-
3
-
-
37149041833
-
Molecular classification and correlates in colorectal cancer
-
Ogino S., and Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn 10 (2008) 13-27
-
(2008)
J Mol Diagn
, vol.10
, pp. 13-27
-
-
Ogino, S.1
Goel, A.2
-
4
-
-
33845608798
-
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
-
Jass J.R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50 (2007) 113-130
-
(2007)
Histopathology
, vol.50
, pp. 113-130
-
-
Jass, J.R.1
-
5
-
-
67650552462
-
Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas
-
52:1039-45
-
Kalady M.F., Sanchez J., Manilich E., Hammel J., Casey G., and Church J. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas. Dis Colon Rectum (2009) 52:1039-45
-
(2009)
Dis Colon Rectum
-
-
Kalady, M.F.1
Sanchez, J.2
Manilich, E.3
Hammel, J.4
Casey, G.5
Church, J.6
-
6
-
-
67650523047
-
Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer
-
In press
-
Sanchez J., Aung P.P., Merkulova A., Plummer S., Skacel M., Krumroy L., et al. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Br J Cancer (2009) In press
-
(2009)
Br J Cancer
-
-
Sanchez, J.1
Aung, P.P.2
Merkulova, A.3
Plummer, S.4
Skacel, M.5
Krumroy, L.6
-
7
-
-
0038002279
-
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
-
Ribic C.M., Sargent D.J., Moore M.J., Thibodeau S.N., French A.J., Goldberg R.M., et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349 (2003) 247-257
-
(2003)
N Engl J Med
, vol.349
, pp. 247-257
-
-
Ribic, C.M.1
Sargent, D.J.2
Moore, M.J.3
Thibodeau, S.N.4
French, A.J.5
Goldberg, R.M.6
-
8
-
-
35948981194
-
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy
-
Shen L., Catalano P.J., Benson III A.B., O'Dwyer P., Hamilton S.R., Issa J.P., et al. Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res 13 (2007) 6093-6098
-
(2007)
Clin Cancer Res
, vol.13
, pp. 6093-6098
-
-
Shen, L.1
Catalano, P.J.2
Benson III A.B.3
O'Dwyer, P.4
Hamilton, S.R.5
Issa, J.P.6
-
9
-
-
0041524111
-
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer
-
Van Rijnsoever M., Elsaleh H., Joseph D., McCaul K., and Iacopetta B. CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Clin Cancer Res 9 (2003) 2898-2903
-
(2003)
Clin Cancer Res
, vol.9
, pp. 2898-2903
-
-
Van Rijnsoever, M.1
Elsaleh, H.2
Joseph, D.3
McCaul, K.4
Iacopetta, B.5
-
10
-
-
57849086513
-
Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?
-
Iacopetta B., Kawakami K., and Watanabe T. Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?. Int J Clin Oncol 13 (2008) 498-503
-
(2008)
Int J Clin Oncol
, vol.13
, pp. 498-503
-
-
Iacopetta, B.1
Kawakami, K.2
Watanabe, T.3
-
11
-
-
38649099966
-
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
-
Lievre A., Bachet J.B., Boige V., Cayre A., Le Corre D., Buc E., et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 26 (2008) 374-379
-
(2008)
J Clin Oncol
, vol.26
, pp. 374-379
-
-
Lievre, A.1
Bachet, J.B.2
Boige, V.3
Cayre, A.4
Le Corre, D.5
Buc, E.6
-
12
-
-
0035918589
-
Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival
-
Rosty C., Chazal M., Etienne M.C., Letoublon C., Bourgeon A., Delpero J.R., et al. Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival. Int J Cancer 95 (2001) 162-167
-
(2001)
Int J Cancer
, vol.95
, pp. 162-167
-
-
Rosty, C.1
Chazal, M.2
Etienne, M.C.3
Letoublon, C.4
Bourgeon, A.5
Delpero, J.R.6
-
13
-
-
57449095367
-
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer
-
Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, et al. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol 20082008;26:5705-12.
-
J Clin Oncol 20082008
, vol.26
, pp. 5705-5712
-
-
Di Nicolantonio, F.1
Martini, M.2
Molinari, F.3
Sartore-Bianchi, A.4
Arena, S.5
Saletti, P.6
-
14
-
-
30944445619
-
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer
-
Masi G., Cupini S., Marcucci L., Cerri E., Loupakis F., Allegrini G., et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 13 (2006) 58-65
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 58-65
-
-
Masi, G.1
Cupini, S.2
Marcucci, L.3
Cerri, E.4
Loupakis, F.5
Allegrini, G.6
-
15
-
-
0036234167
-
Does MSI-low exist?
-
Tomlinson I., Halford S., Aaltonen L., Hawkins N., Ward R., Tomlinson I., et al. Does MSI-low exist?. J Pathol 197 (2002) 6-13
-
(2002)
J Pathol
, vol.197
, pp. 6-13
-
-
Tomlinson, I.1
Halford, S.2
Aaltonen, L.3
Hawkins, N.4
Ward, R.5
Tomlinson, I.6
-
16
-
-
0034654669
-
MethyLight: a high-throughput assay to measure DNA methylation
-
E32
-
Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Blake C., Shibata D., et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: (2000) E32
-
(2000)
Nucleic Acids Res
, vol.28
-
-
Eads, C.A.1
Danenberg, K.D.2
Kawakami, K.3
Saltz, L.B.4
Blake, C.5
Shibata, D.6
-
17
-
-
0035710246
-
DNA methylation analysis by MethyLight technology
-
Trinh B.N., Long T.I., and Laird P.W. DNA methylation analysis by MethyLight technology. Methods 25 (2001) 456-462
-
(2001)
Methods
, vol.25
, pp. 456-462
-
-
Trinh, B.N.1
Long, T.I.2
Laird, P.W.3
-
18
-
-
19944365184
-
Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases
-
Buckowitz A., Knaebel H.P., Benner A., Blaker H., Gebert J., Kienle P., et al. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer 92 (2005) 1746-1753
-
(2005)
Br J Cancer
, vol.92
, pp. 1746-1753
-
-
Buckowitz, A.1
Knaebel, H.P.2
Benner, A.3
Blaker, H.4
Gebert, J.5
Kienle, P.6
-
19
-
-
16644376564
-
Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases
-
Haddad R., Ogilvie R.T., Croitoru M., Muniz V., Gryfe R., Pollet A., et al. Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases. Ann Surg Oncol 11 (2004) 977-982
-
(2004)
Ann Surg Oncol
, vol.11
, pp. 977-982
-
-
Haddad, R.1
Ogilvie, R.T.2
Croitoru, M.3
Muniz, V.4
Gryfe, R.5
Pollet, A.6
-
20
-
-
33745714364
-
CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer
-
Kim Y.H., Petko Z., Dzieciatkowski S., Lin L., Ghiassi M., Stain S., et al. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 45 (2006) 781-789
-
(2006)
Genes Chromosomes Cancer
, vol.45
, pp. 781-789
-
-
Kim, Y.H.1
Petko, Z.2
Dzieciatkowski, S.3
Lin, L.4
Ghiassi, M.5
Stain, S.6
-
21
-
-
33750211241
-
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
-
Miranda E., Destro A., Malesci A., Balladore E., Bianchi P., Baryshnikova E., et al. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer 95 (2006) 1101-1107
-
(2006)
Br J Cancer
, vol.95
, pp. 1101-1107
-
-
Miranda, E.1
Destro, A.2
Malesci, A.3
Balladore, E.4
Bianchi, P.5
Baryshnikova, E.6
-
22
-
-
58749102224
-
High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice
-
Santini D., Loupakis F., Vincenzi B., Floriani I., Stasi I., Canestrari E., et al. High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice. Oncologist 13 (2008) 1270-1275
-
(2008)
Oncologist
, vol.13
, pp. 1270-1275
-
-
Santini, D.1
Loupakis, F.2
Vincenzi, B.3
Floriani, I.4
Stasi, I.5
Canestrari, E.6
-
23
-
-
51649084560
-
Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer
-
Artale S., Sartore-Bianchi A., Veronese S.M., Gambi V., Sarnataro C.S., Gambacorta M., et al. Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. J Clin Oncol 26 (2008) 4217-4219
-
(2008)
J Clin Oncol
, vol.26
, pp. 4217-4219
-
-
Artale, S.1
Sartore-Bianchi, A.2
Veronese, S.M.3
Gambi, V.4
Sarnataro, C.S.5
Gambacorta, M.6
-
24
-
-
33845605907
-
Colorectal serrated adenocarcinoma
-
Makinen M.J. Colorectal serrated adenocarcinoma. Histopathology 50 (2007) 131-150
-
(2007)
Histopathology
, vol.50
, pp. 131-150
-
-
Makinen, M.J.1
|